Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Second EUA For Mask Decontamination Tech Goes To Steris

Executive Summary

The US FDA has issued an emergency use authorization permitting the Steris V-PRO to be used to decontaminate masks used by medical professionals during the COVID-19 pandemic. The technology could get as many as 750,000 more clean N95 masks to medical personnel each day, the agency says.

You may also be interested in...



Study Recommends Hydrogen Peroxide For N95 Decontamination

Research suggests N95 respirators used by medical staff can be safely decontaminated at least two to three times, with hydrogen peroxide vapor the most effective decontamination method.

It’s Raining EUAs: US FDA Drops Slew Of EUAs In Response To COVID-19

While US regulators have ramped up the number of authorizations they’ve granted to companies on an emergency basis in response to the COVID-19 crisis, they really kicked things into high gear in just the past few days. On 10 April the agency issued a record number of EUAs in response to the pandemic.

Compounders Gain Flexibility In Quality Standards Due To PPE Shortages

The US FDA will allow pharmacy compounders to use non-sterile masks and gloves in cleanrooms, but risk strategies must be in place to ensure products are as contaminant-free as possible. Discretion responds to the current shortage of protective gear  due to the COVID-19 pandemic.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel